{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:06:26Z","timestamp":1788404786049,"version":"build-2803163510"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Polycystic ovary syndrome (PCOS) is a female endocrine disease with a high incidence. At present, drug treatment is still the main therapeutic strategy for PCOS. Traditional Chinese medicine has a long history in the treatment of menstrual disorders. Shouwu Jiangqi Decoction (SWJQD) is a traditional herbal medicine prescribed in a clinical setting as a remedy for PCOS. Acupuncture also plays an important role in regulating the menstrual cycle and treating PCOS. This study aims to examine the efficacy and safety of the combination of SWJQD and acupuncture in the treatment of PCOS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This randomized controlled trial will be conducted with a total of 81 participants diagnosed with PCOS. The participants will be randomly divided into 3 treatment groups: group A will receive SWJQD combined with acupuncture; group B, SWJQD combined with sham acupuncture; and group C, metformin. Each treatment will last 3 months. The primary outcomes include the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index and the Oral Glucose Tolerance Test. The secondary outcome measures include sex hormone levels, body mass index, ovulation rate, clinical pregnancy rate, and complete genome sequencing data. Adverse events will be recorded during the intervention and follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study will investigate whether the combination of SWJQD and acupuncture can alleviate the clinical symptoms and improve insulin resistance in patients with PCOS. The results of this study are expected to provide clinical evidence for the application of the combination of SWJQD and acupuncture in patients with PCOS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration:<\/jats:title>\n            <jats:p>Chinese Clinical Trial Registry: ChiCTR1900028106, ChiMCT1900002826 (registered on December 12, 2019).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019045","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T10:11:28Z","timestamp":1584699088000},"page":"e19045","source":"Crossref","is-referenced-by-count":11,"title":["Clinical effects of Shou-Wu Jiang-Qi Decoction combined acupuncture on the treatment of Polycystic Ovarian Syndrome with kidney deficiency, phlegm and blood stasisness"],"prefix":"10.1097","volume":"99","author":[{"given":"Wenting","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic Ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic Ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"R3-20230915","first-page":"161","article-title":"Nutrient patterns and risk of polycystic ovary syndrome","volume":"20","author":"Eslamian","year":"2019","journal-title":"J Reprod Infertil"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00281-019-00737-4","article-title":"Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?","volume":"41","author":"Popovic","year":"2019","journal-title":"Semin Immunopathol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S0954422418000136","article-title":"Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome","volume":"31","author":"Barrea","year":"2018","journal-title":"Nutr Res Rev"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/ijmr.IJMR_1937_17","article-title":"Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India","volume":"150","author":"Ganie","year":"2019","journal-title":"Indian J Med Res"},{"key":"R7-20230915","first-page":"1225","volume":"25","author":"Qi","year":"2019","journal-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40279-014-0291-6","article-title":"Mental health and physical activity in women with polycystic ovary syndrome: a brief review","volume":"45","author":"Conte","year":"2015","journal-title":"Sports medicine (Auckland, N Z )"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"key":"R11-20230915","first-page":"132","article-title":"Association between sex steroids and oxidative status with vitamin D levels in follicular fluid of non-obese PCOS and healthy women","volume":"20","author":"Masjedi","year":"2019","journal-title":"J Reprod Infertil"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2014.12.003","article-title":"Metabolic risk in PCOS: phenotype and adiposity impact","volume":"26","author":"Moran","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/humupd\/dmy045","article-title":"Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome","volume":"25","author":"Pundir","year":"2019","journal-title":"Hum Reprod Update"},{"key":"R15-20230915","first-page":"Cd013505","article-title":"Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome","volume":"12","author":"Sharpe","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20230915","first-page":"Cd010287","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"5","author":"Franik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20230915","first-page":"Cd009526","article-title":"Ovarian surgery for symptom relief in women with polycystic ovary syndrome","volume":"11","author":"Lepine","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"E934","DOI":"10.1152\/ajpendo.00039.2013","article-title":"Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial","volume":"304","author":"Johansson","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R19-20230915","first-page":"Cd007689","article-title":"Acupuncture for polycystic ovarian syndrome","volume":"7","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/GCO.0000000000000582","article-title":"The efficacy of using acupuncture in managing polycystic ovarian syndrome","volume":"31","author":"Chen","year":"2019","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40199-019-00312-0","article-title":"A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS)","volume":"27","author":"Moini Jazani","year":"2019","journal-title":"DARU"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11655-015-2147-9","article-title":"Potent therapeutic effects of Shouwu Jiangqi decoction on polycystic ovary syndrome with insulin resistance in rats","volume":"22","author":"Wang","year":"2016","journal-title":"Chin J Integr Med"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod (Oxford, England)"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2011.06.040","article-title":"Defining hirsutism in Chinese women: a cross-sectional study","volume":"96","author":"Zhao","year":"2011","journal-title":"Fertil Steril"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-09-0298","article-title":"Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome","volume":"161","author":"Ni","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/humrep\/del142","article-title":"Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome","volume":"21","author":"Chen","year":"2006","journal-title":"Hum Reprod"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1142\/S0192415X17500252","article-title":"Chinese herbal medicine for the optimal management of polycystic ovary syndrome","volume":"45","author":"Ong","year":"2017","journal-title":"Am J Chin Med"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"e12942","DOI":"10.1097\/MD.0000000000012942","article-title":"Oriental herbal medicine and moxibustion for polycystic ovary syndrome: a meta-analysis","volume":"97","author":"Kwon","year":"2018","journal-title":"Medicine"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:20:18Z","timestamp":1694816418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019045"}},"subtitle":["Study protocol clinical trial (SPIRIT Compliant)"],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019045","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}